CATX
Price
$2.35
Change
-$0.07 (-2.89%)
Updated
May 9 closing price
Capitalization
751.25M
3 days until earnings call
INBS
Price
$1.21
Change
+$0.01 (+0.83%)
Updated
May 9 closing price
Capitalization
11.55M
Ad is loading...

CATX vs INBS

Header iconCATX vs INBS Comparison
Open Charts CATX vs INBSBanner chart's image
Perspective Therapeutics
Price$2.35
Change-$0.07 (-2.89%)
Volume$363.97K
Capitalization751.25M
Intelligent Bio Solutions
Price$1.21
Change+$0.01 (+0.83%)
Volume$142.76K
Capitalization11.55M
CATX vs INBS Comparison Chart
Loading...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CATX vs. INBS commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CATX is a Hold and INBS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (CATX: $2.35 vs. INBS: $1.21)
Brand notoriety: CATX and INBS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CATX: 50% vs. INBS: 140%
Market capitalization -- CATX: $751.25M vs. INBS: $11.55M
CATX [@Medical Specialties] is valued at $751.25M. INBS’s [@Medical Specialties] market capitalization is $11.55M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CATX’s FA Score shows that 0 FA rating(s) are green whileINBS’s FA Score has 1 green FA rating(s).

  • CATX’s FA Score: 0 green, 5 red.
  • INBS’s FA Score: 1 green, 4 red.
According to our system of comparison, both CATX and INBS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CATX’s TA Score shows that 6 TA indicator(s) are bullish while INBS’s TA Score has 4 bullish TA indicator(s).

  • CATX’s TA Score: 6 bullish, 4 bearish.
  • INBS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CATX is a better buy in the short-term than INBS.

Price Growth

CATX (@Medical Specialties) experienced а -8.20% price change this week, while INBS (@Medical Specialties) price change was -11.03% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.49%. For the same industry, the average monthly price growth was +3.17%, and the average quarterly price growth was -3.96%.

Reported Earning Dates

CATX is expected to report earnings on Aug 08, 2025.

INBS is expected to report earnings on May 09, 2023.

Industries' Descriptions

@Medical Specialties (-1.49% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CATX($751M) has a higher market cap than INBS($11.5M). INBS YTD gains are higher at: -13.571 vs. CATX (-26.332). INBS has higher annual earnings (EBITDA): -12.05M vs. CATX (-39.08M). CATX has more cash in the bank: 9.24M vs. INBS (1.12M). INBS has less debt than CATX: INBS (1.08M) vs CATX (2.55M). INBS has higher revenues than CATX: INBS (2.46M) vs CATX (0).
CATXINBSCATX / INBS
Capitalization751M11.5M6,530%
EBITDA-39.08M-12.05M324%
Gain YTD-26.332-13.571194%
P/E RatioN/A0.06-
Revenue02.46M-
Total Cash9.24M1.12M826%
Total Debt2.55M1.08M236%
FUNDAMENTALS RATINGS
CATX: Fundamental Ratings
CATX
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
35
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CATXINBS
RSI
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INBS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACLX57.551.29
+2.29%
Arcellx
CRDF2.660.03
+1.14%
Cardiff Oncology
VTR66.010.43
+0.66%
Ventas
TKLF3.80-0.04
-1.04%
Tokyo Lifestyle Co Ltd
CGC1.31-0.03
-2.24%
Canopy Growth Corp

CATX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CATX has been closely correlated with STRR. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CATX jumps, then STRR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
-2.89%
STRR - CATX
88%
Closely correlated
+5.98%
SHC - CATX
32%
Poorly correlated
-0.76%
FLGT - CATX
26%
Poorly correlated
+6.14%
ANPCF - CATX
26%
Poorly correlated
N/A
PSNL - CATX
24%
Poorly correlated
-2.33%
More

INBS and

Correlation & Price change

A.I.dvisor tells us that INBS and NNOX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INBS and NNOX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBS
1D Price
Change %
INBS100%
+0.83%
NNOX - INBS
31%
Poorly correlated
+1.16%
SMLR - INBS
28%
Poorly correlated
-1.28%
NVNO - INBS
27%
Poorly correlated
+0.55%
TWST - INBS
27%
Poorly correlated
-5.49%
WILLF - INBS
27%
Poorly correlated
N/A
More